Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

The ROS1 Mutation: A Target for a Small Population with Apparent Sensitivity to XALKORI
Sun, 11/13/2011 - 17:10
Author
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

After the last several posts have discussed our friend and lung cancer expert Dr. Ross Camidge, we'll turn to the related topic of ROS mutations, which have been the subject of research by Dr. Ross Camidge (though apparently not named for him) and also researchers at Massachusetts General Hospital. This is a gene for a DNA repair protein, and the tyrosine kinase binding portion (the part that gets turned on to set off a cascade of downstream intracellular events) for ROS1 is very similar to that for ALK. In the lab, ALK inhibitors can also inhibit ROS1, and now the first few patients have been at the same centers that have done the initial work with XALKORI (crizotinib) -- Massachusetts General Hospital, University of Colorado, University of California at Irvine, and now Peter MacCallum Cancer Centre in Melbourne, Australia -- are also studying this agent in people with a ROS1 mutation. Apparently, the results with XALKORI in the few ROS1 mutation patients thus far are very encouraging, though this work hasn't been published or presented yet in a large forum. Apparently Dr. Alice Shaw from Massachusetts General Hospital will be the lead author on a publication about to be published in the next week or so. I'll share details when it's available in the public domain.

How common is the mutation and who has it? Unfortunately, this group is so small that it makes the ALK positive population look big. It's looking like about 1% of the lung cancer population, and these are again the patients who are never-smokers and have an adenocarcinoma, with pure bronchiololoalveolar carcinoma (BAC) also over-represented, younger patients, and perhaps a little more common in Asian than non-Asian patients. These are also patients who haven't tested positive for EGFR, KRAS, or ALK, or other mutations being tested for by the Lung Cancer Mutation Consortium, for that matter.

ROS1 testing isn't commercially available, and apparently at this time it's pretty much limited to labs at Massachusetts General Hospital and the University of Colorado right now. Neither Drs. Camidge nor Shaw were recommending that broad screening should be done, but it is a stronger consideration for patients who have the clinical characteristics associated with a higher probability and who test negative for other mutations.

Stay tuned. We'll have more on this in the next few weeks to months. It's still very early in this developing story.

Next Previous link

Previous PostNext Post

Related Content

Forum Discussions

Hi snickerdoodle, I'm sorry you're going through this worry. Cea levels for nsclc don't really inform treatment decisions. They sometimes forewarn the coming of progression but sometimes progression doesn't follow a...

I appreciate the comments. I also want to correct my mistake in CEA level- I forgot the decimal. In the past year, my level has increased from 4.7 to 28.3, NOT...

Hi Rick and welcome to Grace. I'm sorry you're going through this. Ethically or legally we can't comment on reports.
Cancer and infection look alike on film and they both cause...

I just saw this link on our fb page. Scanxiety is unfortunately real enough to have a term everyone knows.  Cancer or no (and I'm going for no) you can use...

I completely understand about not being able to comment on reports, I appreciate the support and positive thinking. I am at peace now and am going to remain hopeful-positive until we...

I hope you keep us posted. and Waiting is always the hardest part.

Recent Comments

JOIN THE CONVERSATION
CEA 28.3
By snickerdoodle531 on Wed, 06/22/2022 - 16:05
Hi snickerdoodle, I'm sorry…
By snickerdoodle531 on Wed, 06/22/2022 - 10:52
Read through this thread. As…
By JanineT Forum … on Wed, 06/15/2022 - 11:20
Tagrix vs Tagrisso
By JanineT Forum … on Tue, 06/14/2022 - 23:25